home All News open_in_new Full Article

Un fármaco experimental podría beneficiar a algunos pacientes con una forma rara de ELA

Existe un tipo raro y muy agresivo de esclerosis lateral amiotrófica (ELA) de aparición temprana contra la que un fármaco experimental, probado en un grupo reducido de pacientes, ha logrado que algunos muestren mejoras.


today 5 d. ago attach_file Politics

attach_file Transport
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics


ID: 4104758658
Add Watch Country

arrow_drop_down